Immuno-hyperthermia effected by antibody-conjugated nanoparticles selectively targets and eradicates individual cancer cells-Reference-Cited by-同舟云学术

Immuno-hyperthermia effected by antibody-conjugated nanoparticles selectively targets and eradicates individual cancer cells

Published:2021-06-19 Issue:13 Volume:20 Page:1221-1230
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

Kagawa Tetsuya¹^ORCID,Matsumi Yuki¹,Aono Hiromichi²,Ohara Toshiaki³,Tazawa Hiroshi¹^ORCID,Shigeyasu Kunitoshi¹,Yano Shuya¹⁴,Takeda Sho¹,Komatsu Yasuhiro¹,Hoffman Robert M.⁵⁶,Fujiwara Toshiyoshi¹^ORCID,Kishimoto Hiroyuki¹^ORCID

Affiliation:

1. Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan

2. Graduate School of Science and Engineering, Ehime University, Matsuyama, Japan

3. Department of Pathology and Experimental Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

4. Center for Graduate Medical Education, Okayama University Hospital, Okayama, Japan

5. AntiCancer, Inc, San Diego, CA, USA

6. Department of Surgery, University of California, San Diego, USA

Funder

Japan Society for the Promotion of Science

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384101.2021.1915604

Reference15 articles.